id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
687,,,,,,,,,,,,,,,2024-05-14T16:42:01+06:00,BSH - BSH - H12205250707,Left,Letrozole,,,"Received 4 Cycles AC followed by 12 Cycle paclitaxel weekly up to 17.04.21 (Outside)>
Started Tamoxifen for 1 year then switched to Letrozole due to impaired LFT",2023-07-24,,2023-07-24,,2023-07-24,,,Breast,114,Upper middle class,BSBSC-240000114,SADIKA JESMIN,1912837575,1978-05-14,Female,,,,,Dr Md Arifur Rahman,BSH,,1st Line,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.2- Upper-inner quadrant of breast,Breast,Left,,,Stable,Alive,SD,,,,,,,,,,,,,,,,,CA15.3,14.4,,2023-07-23,687.0
687,,,,,,,,,,,,,,,2024-05-14T16:42:01+06:00,BSH - BSH - H12205250707,Left,Letrozole,,,"Received 4 Cycles AC followed by 12 Cycle paclitaxel weekly up to 17.04.21 (Outside)>
Started Tamoxifen for 1 year then switched to Letrozole due to impaired LFT",2023-07-24,,2023-07-24,,2023-07-24,,,Breast,114,Upper middle class,BSBSC-240000114,SADIKA JESMIN,1912837575,1978-05-14,Female,,,,,Dr Md Arifur Rahman,BSH,,1st Line,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.2- Upper-inner quadrant of breast,Breast,Left,,,Stable,Alive,SD,,,,,,,,,,,,,,,,,CA125,10.0,,2023-07-23,687.0
118,,,,,,,,,,,,,,,2024-05-14T16:42:01+06:00,BSH - H12205250707,Left,Letrozole,,,"Received 4 Cycles AC followed by 12 Cycle paclitaxel weekly up to 17.04.21 (Outside)>
Started Tamoxifen for 1 year then switched to Letrozole due to impaired LFT",2023-07-24,,2023-07-24,,2023-07-24,,,Breast,114,Upper middle class,BSBSC-240000114,SADIKA JESMIN,1912837575,1978-05-14,Female,,,,,Dr Md Arifur Rahman,BSH,,1st Line,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,C50.2- Upper-inner quadrant of breast,Breast,Left,,,Stable,Alive,SD,,,,,,,,,,,,,,,,,,,,,
